Sushil Patel
Chief Executive Officer chez REPLIMUNE GROUP, INC.
Fortune : 2 M $ au 31/03/2024
Profil
Sushil Patel is currently the Chief Executive Officer & Director at Replimune Group, Inc. since 2024 and an Independent Director at Revolution Medicines, Inc. since 2022.
Previously, he worked at Genentech, Inc. from 2002 to 2021, where he held the position of Vice President-Franchise & Head-Oncology from 2008 to 2021.
Dr. Patel completed his graduate degree at Imperial College London in 1993, obtained a doctorate degree from the University of London in 1999, and received his undergraduate degree from the University of Warwick in 1992.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REPLIMUNE GROUP, INC.
0,38% | 01/04/2024 | 232 208 ( 0,38% ) | 2 M $ | 31/03/2024 |
| 10/04/2024 | 15 700 ( 0,01% ) | 506 011 $ | 31/03/2024 |
Postes actifs de Sushil Patel
| Sociétés | Poste | Début |
|---|---|---|
| REPLIMUNE GROUP, INC. | Chief Executive Officer | 01/04/2024 |
| REVOLUTION MEDICINES, INC. | Director/Board Member | 16/06/2022 |
Anciens postes connus de Sushil Patel
| Sociétés | Poste | Fin |
|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2021 |
Formation de Sushil Patel
| Imperial College London | Graduate Degree |
| University of London | Doctorate Degree |
| University of Warwick | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| REVOLUTION MEDICINES, INC. | Health Technology |
| REPLIMUNE GROUP, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
